论文部分内容阅读
原发性肝癌手术切除仍是目前获得根治的最有效途径,但肝癌根治性切除术后复发甚为常见,我所资料表明,肝癌术后1年复发率17.1%,5年复发率可高达61.5%.因此,有效地预防和治疗肝癌术后的复发是进一步提高疗效的关键.本文报告自1994年5月以来采用以生物治疗为基础进行预防肝癌术后复发探索.本组原发性肝癌共41例.其中男39例、女2例,年龄30～73岁,肿瘤位于右叶31例,左叶9例,累及二叶1例,肿瘤直径>5cm者16例,<5cm者23例(3例术前破裂).全部病例均经病理证实为肝细胞癌,除8
Surgical resection of primary liver cancer is still the most effective way to achieve radical cure. However, recurrence after radical resection of liver cancer is very common. Our data show that the recurrence rate of liver cancer after one year is 17.1%, and the recurrence rate can reach 61.5 for 5 years. Therefore, effective prevention and treatment of recurrence after liver cancer surgery is the key to further improve the curative effect. This article reports on the use of biological therapy based on the prevention of recurrence of liver cancer after exploration since May 1994. This group of primary liver cancer 41 cases, including 39 males and 2 females, aged 30-73 years old, with 31 cases of tumor located in the right lobe, 9 cases of left lobe, 1 case involving 2 lobes, 16 cases with tumor diameter >5cm, 23 cases <5cm ( 3 cases of preoperative rupture). All cases were pathologically confirmed as hepatocellular carcinoma, except 8